{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:55:16Z","timestamp":1787885716263,"version":"build-2784847793"},"reference-count":32,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Vascular Disease Research"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Coronary heart disease (CHD) is a prevalent complication associated with type 2 diabetes mellitus (T2DM), and the incidence of T2DM with CHD has seen a steady rise over the preceding years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the altered expression of LINC00893 and miR-103a-3p in T2DM and T2DM with CHD, as well as to assess their clinical significance in T2DM-CHD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The LINC00893 and miR-103a-3p expression was detected by RT-qPCR. ROC curves were used to analyze the diagnostic significance of LINC00893 and miR-103a-3p in T2DM patients with CHD. The Kaplan-Meier curve was used to analyze the prognostic significance of LINC00893 in the occurrence of Major Adverse Cardiovascular Events (MACEs) of T2DM with CHD patients. Dual-luciferase reporter assay was used to confirm the regulatory relationship between LINC00893 and miR-103a-3p.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>LINC00893 and miR-103a-3p were down-regulated and up-regulated in T2DM with CHD patients, respectively and had diagnostic value in T2DM with CHD patients. In addition, patients with low levels of LINC00893 are more likely to develop MACE, and LINC00893 could regulate the expression of miR-103a-3p.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>LINC00893 may affect disease progression in T2DM patients with CHD by regulating miR-103a-3p.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/14791641251407678","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T18:39:06Z","timestamp":1772131146000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical significance of LINC00893 and miR-103a-3p in type 2 diabetes mellitus patients with coronary heart disease"],"prefix":"10.1177","volume":"23","author":[{"given":"Huansong","family":"Fang","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Shantou University Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Han","sequence":"additional","affiliation":[{"name":"The Affiliated Guangdong Second Provincial General Hospital of Jinan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8063-9395","authenticated-orcid":false,"given":"Jiaoding","family":"Tian","sequence":"additional","affiliation":[{"name":"Qinhuangdao Hospital of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghua","family":"Liang","sequence":"additional","affiliation":[{"name":"Central People\u2019s Hospital of Zhanjiang"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.151"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60484-9"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19020647"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.119.316065"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-019-0570-z"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1055\/a-2077-5177"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-023-03601-4"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02637-4"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.3233\/CBM-190543"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-023-09535-7"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/6072438"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2022.63.6.520"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1080\/08941939.2020.1738602"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.031435"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3774"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2018.03.044"},{"key":"e_1_3_4_18_2","first-page":"315","article-title":"Chinese Guidelines for the prevention and treatment of Type 2 diabetes (2020 edition)","volume":"13","author":"Association DSoCM","year":"2021","unstructured":"Association DSoCM. Chinese Guidelines for the prevention and treatment of Type 2 diabetes (2020 edition). Chinese Journal of Diabetes Mellitus 2021; 13: 315\u2013409.","journal-title":"Chinese Journal of Diabetes Mellitus"},{"key":"e_1_3_4_19_2","first-page":"265","article-title":"Primary care guidelines for stable coronary heart disease","volume":"20","author":"Chinese Medical Association, Journal of Chinese Medical Association and Practice CMABoG","year":"2021","unstructured":"Chinese Medical Association, Journal of Chinese Medical Association and Practice CMABoG. Primary care guidelines for stable coronary heart disease. Chinese Journal of General Practitioners 2021; 20: 265\u2013273.","journal-title":"Chinese Journal of General Practitioners"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/jat.4465"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1586\/erc.12.52"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1080\/13813455.2020.1843498"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24070"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01531-7"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.992252"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1080\/00015385.2022.2040822"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1177\/0003319720951411"},{"key":"e_1_3_4_28_2","first-page":"376","article-title":"Expression of lncRNA-ANRIL in patients with coronary heart disease before and after treatment and its short-term prognosis predictive value","volume":"24","author":"Liu ZF","year":"2020","unstructured":"Liu ZF, Hu WW, Li R, et al. Expression of lncRNA-ANRIL in patients with coronary heart disease before and after treatment and its short-term prognosis predictive value. Eur Rev Med Pharmacol Sci 2020; 24: 376\u2013384.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23196"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8002318"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.682959"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1080\/00015385.2023.2209448"},{"key":"e_1_3_4_33_2","first-page":"12859","article-title":"LncRNA UCA1 stimulates the repair of hyperglycemic vascular smooth muscle cells through targeting miR-582-5p","volume":"24","author":"Yang JL","year":"2020","unstructured":"Yang JL, Han NH. LncRNA UCA1 stimulates the repair of hyperglycemic vascular smooth muscle cells through targeting miR-582-5p. Eur Rev Med Pharmacol Sci 2020; 24: 12859\u201312866.","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Diabetes &amp; Vascular Disease Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/14791641251407678","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/14791641251407678","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/14791641251407678","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:20:18Z","timestamp":1777400418000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/14791641251407678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1177\/14791641251407678"],"URL":"https:\/\/doi.org\/10.1177\/14791641251407678","relation":{},"ISSN":["1479-1641","1752-8984"],"issn-type":[{"value":"1479-1641","type":"print"},{"value":"1752-8984","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"article-number":"14791641251407678"}}